Nhi Ny Nguyen, Lan Duong, Minh B Doan, Hoang Duc Nguyen
{"title":"Surface display of LukF-PV on <i>Bacillus subtilis</i> spore for oral administration.","authors":"Nhi Ny Nguyen, Lan Duong, Minh B Doan, Hoang Duc Nguyen","doi":"10.1080/17460913.2025.2480933","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong><i>Bacillus subtilis</i> spores are promising candidates for oral vaccine, serving as carriers for foreign proteins from pathogens. Here we utilized CotB, a spore coat protein, to anchor the LukF-PV from <i>Staphylococcus aureus</i> onto the surface of <i>B. subtilis</i> spores. Our goal was to generate a new <i>B. subtilis</i> strain and assess the capacity of the recombinant spore strain to induce antibody production in mice.</p><p><strong>Methods: </strong>The fusion sequence of <i>cotB-lukF-</i><i>PV</i> was cloned into <i>E. coli</i> and transformed into <i>B. subtilis</i> HT800F. Colony PCR confirmed the generation of the recombinant strain. SporeELISA verified the display of LukF-PV. Mice were orally gavaged with the spore, and the production of IgA antibodies in feces and IgG in blood was evaluated.</p><p><strong>Results: </strong>We generated a new <i>B. subtilis</i> strain, BsHT2332, that integrated the P<i>cotB-cotB-lukF-PV</i> into its genome at <i>amyE</i> locus. BsHT2332 successfully displayed LukF-PV on the spore surface. The recombinant spores induced significant IgA and IgG immune responses in mice.</p><p><strong>Conclusion: </strong>This study demonstrated that <i>B. subtilis</i> spores expressing the <i>S. aureus</i> antigen LukF-PV can induce an immune response. These findings underscore the potential of the <i>B. subtilis</i> spore platform as a promising approach for vaccine development against <i>S. aureus</i>.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"1-9"},"PeriodicalIF":2.5000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future microbiology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1080/17460913.2025.2480933","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Aim: Bacillus subtilis spores are promising candidates for oral vaccine, serving as carriers for foreign proteins from pathogens. Here we utilized CotB, a spore coat protein, to anchor the LukF-PV from Staphylococcus aureus onto the surface of B. subtilis spores. Our goal was to generate a new B. subtilis strain and assess the capacity of the recombinant spore strain to induce antibody production in mice.
Methods: The fusion sequence of cotB-lukF-PV was cloned into E. coli and transformed into B. subtilis HT800F. Colony PCR confirmed the generation of the recombinant strain. SporeELISA verified the display of LukF-PV. Mice were orally gavaged with the spore, and the production of IgA antibodies in feces and IgG in blood was evaluated.
Results: We generated a new B. subtilis strain, BsHT2332, that integrated the PcotB-cotB-lukF-PV into its genome at amyE locus. BsHT2332 successfully displayed LukF-PV on the spore surface. The recombinant spores induced significant IgA and IgG immune responses in mice.
Conclusion: This study demonstrated that B. subtilis spores expressing the S. aureus antigen LukF-PV can induce an immune response. These findings underscore the potential of the B. subtilis spore platform as a promising approach for vaccine development against S. aureus.
期刊介绍:
Future Microbiology delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this increasingly important and vast area of research.